Biogen Inc (BIIB.OQ)
26 May 2017
ZURICH, May 24 A person in Germany treated with Roche Holding AG’s new multiple sclerosis drug Ocrevus has been diagnosed with an often-deadly brain infection after switching from another medication earlier this year, the Swiss drugmaker said on Wednesday.
May 22 Celgene Corp said its oral drug to treat relapsing multiple sclerosis met the main goal of reducing annualized relapse rate, when compared to Biogen Inc's Avonex, in a second late-stage study.
* Biogen acquires Remedy Pharmaceuticals' late-stage drug cirara
* Paulson & Co Inc takes share stake of 3.5 million shares in Dish Network Corp
Biogen Inc has won the dismissal of a proposed shareholder class action claiming executives misled investors about the effect on sales of the death of a patient who had taken the company's new multiple sclerosis drug Tecfidera.
* Biogen Inc former CEO George Scangos's 2016 total compensation $17.7 million versus $16.9 million in 2015 - sec filing Source text - http://bit.ly/2oKp4LQ Further company coverage:
Biogen Inc's quarterly profit blew past analysts' estimates, helped by higher-than-expected sales of its recently launched spinal muscular atrophy drug, Spinraza.
* Shares rise 5.4 pct (Adds conference call details, analyst comments; updates shares)
* Biogen says "we are working to add more assetts to our pipeline": Conf Call
April 25 Biogen Inc reported a 3 percent rise in quarterly revenue, helped by higher-than-expected sales of its newly launched spinal muscular atrophy drug, Spinraza.
|Johnson & Johnson (JNJ.N)||$126.92||-0.61|
|Pfizer Inc. (PFE.N)||$32.14||-0.02|
|Novartis AG (NOVN.S)||CHF78.60||-0.50|
|Merck & Co., Inc. (MRK.N)||$64.92||-0.12|
|Roche Holding Ltd. (ROG.S)||CHF266.60||-0.60|
|Roche Holding Ltd. (RO.S)||CHF267.75||+0.25|
|Bayer AG (BAYGn.DE)||€116.70||-0.05|
|Bayer AG (BAYE.F)||--||--|
|Sanofi SA (SASY.PA)||€87.74||+0.43|
|GlaxoSmithKline plc (GSK.L)||1,643.50||+25.50|